Literature DB >> 9344252

Structure, function, and regulation of human cAMP-dependent protein kinases.

K Taskén1, B S Skålhegg, K A Taskén, R Solberg, H K Knutsen, F O Levy, M Sandberg, S Orstavik, T Larsen, A K Johansen, T Vang, H P Schrader, N T Reinton, K M Torgersen, V Hansson, T Jahnsen.   

Abstract

A large number of hormones, neurotransmitters, and other signaling substances that bind to G-protein-coupled cell-surface receptors have their signals converge at one sole second messenger, cAMP. The question of how specificity can be maintained in a signal-transduction system in which many extracellular signals leading to a vast array of intracellular responses are all mediated through one second-messenger system has been the subject of thorough investigation and a great deal of speculation. An increasing number of cAK isozymes, consisting of homo- or heterodimers of R subunits (RIalpha, RIbeta, RIIalpha, RIIbeta) with associated catalytic subunits (C alpha, Cbeta, Cgamma), may, at least in part, explain this specificity. The various cAK isozymes display distinct biochemical properties, and the heterogeneous subunits of cAK reveal cell-specific expression and differential regulation at the level of gene transcription, mRNA stability, and protein stability in response to a wide range of hormones and other signaling substances. The existence of a number of anchoring proteins specific to either RIIalpha or RIIbeta, and which localize cAKII isozymes toward distinct substrates at defined subcellular loci, strongly supports the idea that specific functions can be assigned to the various cAK isozymes. The demonstration that selective activation of cAKI is necessary and sufficient for cAMP-mediated inhibition of T-cell proliferation, and the observation that T-cell activation is associated with redistribution and colocalization of cAKI to the TCR, is also compatible with the notion of isozyme-specific effects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9344252     DOI: 10.1016/s1040-7952(97)80019-5

Source DB:  PubMed          Journal:  Adv Second Messenger Phosphoprotein Res        ISSN: 1040-7952


  47 in total

1.  Cloning and mitochondrial localization of full-length D-AKAP2, a protein kinase A anchoring protein.

Authors:  L Wang; R K Sunahara; A Krumins; G Perkins; M L Crochiere; M Mackey; S Bell; M H Ellisman; S S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  Cloning and mapping of human PKIB and PKIG, and comparison of tissue expression patterns of three members of the protein kinase inhibitor family, including PKIA.

Authors:  L Zheng; L Yu; Q Tu; M Zhang; H He; W Chen; J Gao; J Yu; Q Wu; S Zhao
Journal:  Biochem J       Date:  2000-07-15       Impact factor: 3.857

3.  The two regulatory subunits of aplysia cAMP-dependent protein kinase mediate distinct functions in producing synaptic plasticity.

Authors:  Jinming Liu; Jiang-Yuan Hu; Samuel Schacher; James H Schwartz
Journal:  J Neurosci       Date:  2004-03-10       Impact factor: 6.167

Review 4.  Phosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatment.

Authors:  Isaac Levy; Anelia Horvath; Monalisa Azevedo; Rodrigo Bertollo de Alexandre; Constantine A Stratakis
Journal:  Curr Opin Pharmacol       Date:  2011-10-31       Impact factor: 5.547

5.  Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update.

Authors:  Anélia Horvath; Jérôme Bertherat; Lionel Groussin; Marine Guillaud-Bataille; Kitman Tsang; Laure Cazabat; Rosella Libé; Elaine Remmers; Fernande René-Corail; Fabio Rueda Faucz; Eric Clauser; Alain Calender; Xavier Bertagna; J Aidan Carney; Constantine A Stratakis
Journal:  Hum Mutat       Date:  2010-04       Impact factor: 4.878

Review 6.  The cAMP pathway and the control of adrenocortical development and growth.

Authors:  Cyrille de Joussineau; Isabelle Sahut-Barnola; Isaac Levy; Emmanouil Saloustros; Pierre Val; Constantine A Stratakis; Antoine Martinez
Journal:  Mol Cell Endocrinol       Date:  2011-10-15       Impact factor: 4.102

7.  Protein kinase A effects of an expressed PRKAR1A mutation associated with aggressive tumors.

Authors:  Elise Meoli; Ioannis Bossis; Laure Cazabat; Manos Mavrakis; Anelia Horvath; Sotiris Stergiopoulos; Miriam L Shiferaw; Glawdys Fumey; Karine Perlemoine; Michael Muchow; Audrey Robinson-White; Frank Weinberg; Maria Nesterova; Yianna Patronas; Lionel Groussin; Jérôme Bertherat; Constantine A Stratakis
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

Review 8.  Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues.

Authors:  Giovanna Mantovani; Anna Spada; Francesca Marta Elli
Journal:  Nat Rev Endocrinol       Date:  2016-04-22       Impact factor: 43.330

9.  8-Cl-adenosine inhibits proliferation and causes apoptosis in B-lymphocytes via protein kinase A-dependent and independent effects: implications for treatment of Carney complex-associated tumors.

Authors:  Audrey J Robinson-White; Ioannis Bossis; Hui-Pin Hsiao; Maria Nesterova; Wolfgang W Leitner; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2009-09-22       Impact factor: 5.958

10.  The mRNA and protein expression of A-kinase anchor proteins 13 in human colorectal cancer.

Authors:  Jian-Kun Hu; Ling Wang; Yuan Li; Kun Yang; Peng Zhang; Xin-Zu Chen; Rong Wang; Zong-Guang Zhou
Journal:  Clin Exp Med       Date:  2009-09-25       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.